(0.33%) 5 108.25 points
(0.75%) 38 670 points
(0.58%) 17 753 points
(0.10%) $79.03
(-0.20%) $2.03
(0.07%) $2 311.30
(-0.01%) $26.83
(1.77%) $979.60
(-0.17%) $0.931
(-0.62%) $10.92
(-0.25%) $0.796
(0.48%) $91.56
Live Chart Being Loaded With Signals
Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally...
Stats | |
---|---|
本日の出来高 | 38 009.00 |
平均出来高 | 60 988.00 |
時価総額 | 16.91M |
EPS | £0 ( 2024-05-01 ) |
次の収益日 | ( £0 ) 2024-06-27 |
Last Dividend | £0 ( N/A ) |
Next Dividend | £0 ( N/A ) |
P/E | -4.82 |
ATR14 | £0.235 (0.48%) |
Cambridge Cognition 相関
10 最も正の相関 | |
---|---|
PIN.L | 0.922 |
ICGT.L | 0.917 |
WBI.L | 0.913 |
SGZ.L | 0.911 |
IQE.L | 0.909 |
AMGO.L | 0.906 |
NAIT.L | 0.905 |
GROW.L | 0.903 |
KRPZ.L | 0.902 |
XRH0.L | 0.901 |
10 最も負の相関 | |
---|---|
BA.L | -0.918 |
FCCN.L | -0.911 |
WPS.L | -0.911 |
TIP5.L | -0.9 |
COST.L | -0.899 |
IL0A.L | -0.898 |
RSG.L | -0.897 |
VPAC.L | -0.896 |
KOO.L | -0.894 |
CATC.L | -0.892 |
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Cambridge Cognition 財務諸表
Annual | 2023 |
収益: | £13.52M |
総利益: | £10.80M (79.90 %) |
EPS: | £-0.100 |
FY | 2023 |
収益: | £13.52M |
総利益: | £10.80M (79.90 %) |
EPS: | £-0.100 |
FY | 2022 |
収益: | £12.61M |
総利益: | £9.32M (73.91 %) |
EPS: | £-0.0131 |
FY | 2021 |
収益: | £10.09M |
総利益: | £8.08M (80.04 %) |
EPS: | £0.00563 |
Financial Reports:
No articles found.
Cambridge Cognition
Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB Recruit, an online trial recruitment platform for pharmaceutical and biotechnology companies to identify qualified clinical trial participants in high-need indications, such as Alzheimer's disease; CANTAB Connect that provides digital cognitive assessment solutions for pharmaceutical clinical trials in various therapeutic areas from Phases IIV; and Cognition Kit, a digital health platform, which delivers wearable and smartphone apps for data collection to provide engaging digital health solutions for the enhancement of patient engagement, demonstration of treatment efficacy, and understanding of a disease and a patient's response to medication. It also provides CANTAB Connect Research, a research software that offers sensitive digital measures of cognitive function for various areas of brain research; CANTAB Mobile, a touchscreen memory test used in clinical research of Alzheimer's disease; CANTAB BrainHealth, an online digital health assessment tool to measure and monitor mental wellbeing and cognitive performance in the workplace; CANTAB Insight, a medical device that helps to determine an individual's cognitive health; and NeuroVocalix for an automated administration and scoring of well-validated verbal cognitive assessments?on a secure platform. In addition, the company offers a range of expert consultancy and operational management services to optimize clinical trials and cognitive research, which include neuroscience and technical consultancy, study design, data analysis, study and data management, and reports and interpretation. Cambridge Cognition Holdings Plc was incorporated in 2012 and is based in Cambridge, the United Kingdom.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。